SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer (Q27853293)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
scientific article

    Statements

    SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer (English)
    Erica Hlavin Bell
    0 references
    Arup R Chakraborty
    0 references
    Xiaokui Mo
    0 references
    Ziyan Liu
    0 references
    Konstantin Shilo
    0 references
    Simon Kirste
    0 references
    Petra Stegmaier
    0 references
    Maureen McNulty
    0 references
    Niki Karachaliou
    0 references
    Gerold Bepler
    0 references
    David P Carbone
    0 references
    Arnab Chakravarti
    0 references
    15 May 2016
    0 references
    22
    0 references
    10
    0 references
    2396-404
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit